Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Sahar Al-borikan"'
Autor:
Andrew Marshall, Guy Lloyd, Sanjeev Bhattacharyya, Nikhil Patel, Sahar Al-borikan, Thomas A. Treibel, Sveeta Badiani, Jet van Zalen, Aeshah Althunayyan
Publikováno v:
International journal of clinical practiceREFERENCES. 75(10)
Aims Serum biomarkers have a potential role in the risk stratification of patients with heart valve disease and may help determine the optimal timing of intervention. Much of the published literature relates to biomarker sampling in a resting state,
Autor:
K. Von Klemperer, Sanjeev Bhattacharyya, Fiona Walker, S. Badiani, Steffen E. Petersen, Bejal Pandya, Sahar Al-borikan, Guy Lloyd, A Bhan
Publikováno v:
International Journal of Cardiology Congenital Heart Disease, Vol 6, Iss, Pp 100237-(2021)
Background: The clinical use and prognostic value of plasma brain natriuretic peptide (NT-proBNP) and soluble suppression of tumourigenicity-2 (sST2) levels are not known in patients with repaired Tetralogy of Fallot (rTOF).Objectives: We evaluated b
Autor:
Sanjeev Bhattacharyya, S. Badiani, Fiona Walker, S. Cullen, Bejal Pandya, Guy Lloyd, K. Von Klemperer, Sahar Al-borikan
Publikováno v:
International Journal of Cardiology Congenital Heart Disease, Vol 1, Iss, Pp 100050-(2020)
Background Cardiopulmonary exercise testing (CPET) provides a comprehensive objective assessment in patients with repaired Tetralogy of Fallot (rTOF). However, the evidence underpinning this practice is scanty as are the mechanisms which drive exerci